BI’s Cyltezo Becomes 15th EU Biosimilar This Year, Adds To Pressure On Humira

 
• By Ian Schofield
Pressure
Biosimilar pressure on AbbVie's Humira is growing with latest approval

More from Approvals

More from Product Reviews